CSPC 2018 has ended
Wednesday, November 7 • 10:30am - 12:00pm
(90 mins) Towards a Canadian Life Sciences Supercluster / Vers un suramoncellement de sciences de la vie canadiennes

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Organized by: The Centre for Drug Research and Development, Barry Gee

Canada has a proud history of international leadership in health research, and in supporting innovation in the global life sciences industry. Despite constituting less than 0.5% of the world population, Canadians produce 5% of the world’s research publications, with a citation rate that ranks amongst the top 6 nations worldwide. However, Canada doesn’t full take advantage of this competitive advantage by translating it into a leading life sciences industry: The winners of the Canadian federal government’s 2018 ‘Supercluster’ funding initiative represented a multitude of industries encompassing digital technologies, oceans, mining, artificial intelligence, smart agri-food, and advanced manufacturing. Jarringly, no life sciences proposals were ultimately supported.

This session will debate the government's decision, and discuss how we can tap into the life sciences sector’s potential to contribute immensely to Canada’s economy and transform into the next Canadian supercluster. Our panelists will share perspectives on two salient topics: (i) the means by which the public and private sectors can best come together to support the growth of Canada's health sciences ecosystem, and (ii) strategies for the federal government to establish comprehensive public policy and work with the private sector to support basic research, build a robust translational and commercialization pathway, and ultimately attract increased venture capital investment to Canada such that we can scale Canadian SMEs, and establish global Canadian anchors.

avatar for Gordon McCauley

Gordon McCauley

President and CEO, The Centre for Drug Research and Development
Gordon McCauley was appointed President and CEO of CDRD in 2017 after serving on the Board for four years. Mr. McCauley is an accomplished life science investor and executive. He has served as President & CEO of Viable Healthworks Corp., a national healthcare service business; President... Read More →

avatar for Dr. Raphael (Rafi) Hofstein

Dr. Raphael (Rafi) Hofstein

President and CEO, MaRS Innovation
Dr. Raphael Hofstein, also known as Rafi, Ph.D. has been the Chief Executive Officer and President of MaRS Innovation since June 2009.Dr. Hofstein joined MaRS Innovation from Israel, where he held the position of President and CEO of Hadasit Ltd., the technology transfer company of... Read More →

Cate McCready

Vice President, External Affairs, BIOTECanada
With fifteen years of practical experience in the field of communications and public affairs Cate McCready joined BIOTECanada in November of 2001 and currently serves in the role of Vice President, External Affairs.Her current role with BIOTECanada encompasses the development of national... Read More →
avatar for Dr. Stéphanie Michaud

Dr. Stéphanie Michaud

President & Chief Executive Officer, BioCanRx
Dr. Stéphanie Michaud is the President and CEO of BioCanRx, a not-for-profit that seeks to accelerate the delivery of innovative immunotherapies from the bench to the bedside. In this position, Stéphanie is responsible for running all facets of the organization. She brings more... Read More →
avatar for Karimah Es Sabar

Karimah Es Sabar

CEO and Partner, Quark Venture Inc.
A highly-recognized Canadian life sciences leader with broad global experience, Karimah Es Sabar has had a successful career spanning multi-national pharmaceutical/biotechnology companies, startups, not-for-profit organizations and venture investment firm. She has provided leadership... Read More →

Wednesday November 7, 2018 10:30am - 12:00pm EST
Delta Ottawa - Capitale